nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Vismodegib—skin cancer	0.166	0.218	CbGbCtD
Sitagliptin—ABCB1—Vismodegib—skin cancer	0.112	0.148	CbGbCtD
Sitagliptin—CYP3A4—Temozolomide—skin cancer	0.0972	0.128	CbGbCtD
Sitagliptin—CYP3A4—Imiquimod—skin cancer	0.0972	0.128	CbGbCtD
Sitagliptin—CYP3A4—Vismodegib—skin cancer	0.0674	0.0886	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—skin cancer	0.0591	0.0777	CbGbCtD
Sitagliptin—CYP2C8—Fluorouracil—skin cancer	0.059	0.0776	CbGbCtD
Sitagliptin—CYP3A4—Vemurafenib—skin cancer	0.0533	0.07	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—skin cancer	0.0305	0.0401	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—skin cancer	0.0183	0.024	CbGbCtD
Sitagliptin—Cough—Imiquimod—skin cancer	0.000731	0.00305	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000731	0.00305	CcSEcCtD
Sitagliptin—Hypertension—Imiquimod—skin cancer	0.000723	0.00302	CcSEcCtD
Sitagliptin—Pneumonia—Dactinomycin—skin cancer	0.000715	0.00299	CcSEcCtD
Sitagliptin—Myalgia—Imiquimod—skin cancer	0.000713	0.00298	CcSEcCtD
Sitagliptin—Arthralgia—Imiquimod—skin cancer	0.000713	0.00298	CcSEcCtD
Sitagliptin—Anxiety—Imiquimod—skin cancer	0.000711	0.00297	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000708	0.00296	CcSEcCtD
Sitagliptin—Discomfort—Imiquimod—skin cancer	0.000705	0.00294	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000704	0.00294	CcSEcCtD
Sitagliptin—Dry mouth—Imiquimod—skin cancer	0.000698	0.00291	CcSEcCtD
Sitagliptin—Decreased appetite—Vemurafenib—skin cancer	0.000697	0.00291	CcSEcCtD
Sitagliptin—Bronchitis—Temozolomide—skin cancer	0.000693	0.0029	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000692	0.00289	CcSEcCtD
Sitagliptin—Fatigue—Vemurafenib—skin cancer	0.000691	0.00289	CcSEcCtD
Sitagliptin—Nasopharyngitis—Fluorouracil—skin cancer	0.000687	0.00287	CcSEcCtD
Sitagliptin—Constipation—Vemurafenib—skin cancer	0.000686	0.00286	CcSEcCtD
Sitagliptin—Hypoaesthesia—Bleomycin—skin cancer	0.00068	0.00284	CcSEcCtD
Sitagliptin—Infection—Imiquimod—skin cancer	0.000679	0.00284	CcSEcCtD
Sitagliptin—Nervous system disorder—Imiquimod—skin cancer	0.000671	0.0028	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Temozolomide—skin cancer	0.00067	0.0028	CcSEcCtD
Sitagliptin—Skin disorder—Imiquimod—skin cancer	0.000664	0.00278	CcSEcCtD
Sitagliptin—Erectile dysfunction—Temozolomide—skin cancer	0.000664	0.00277	CcSEcCtD
Sitagliptin—Weight increased—Temozolomide—skin cancer	0.000656	0.00274	CcSEcCtD
Sitagliptin—Hyperglycaemia—Temozolomide—skin cancer	0.00065	0.00272	CcSEcCtD
Sitagliptin—Pneumonia—Temozolomide—skin cancer	0.000646	0.0027	CcSEcCtD
Sitagliptin—Infestation NOS—Temozolomide—skin cancer	0.000643	0.00268	CcSEcCtD
Sitagliptin—Infestation—Temozolomide—skin cancer	0.000643	0.00268	CcSEcCtD
Sitagliptin—Depression—Temozolomide—skin cancer	0.000641	0.00268	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000637	0.00266	CcSEcCtD
Sitagliptin—Pharyngitis—Dactinomycin—skin cancer	0.000633	0.00264	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Temozolomide—skin cancer	0.00063	0.00263	CcSEcCtD
Sitagliptin—Urinary tract infection—Temozolomide—skin cancer	0.000625	0.00261	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000623	0.0026	CcSEcCtD
Sitagliptin—Insomnia—Imiquimod—skin cancer	0.000619	0.00258	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000617	0.00258	CcSEcCtD
Sitagliptin—Somnolence—Imiquimod—skin cancer	0.000608	0.00254	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Temozolomide—skin cancer	0.000608	0.00254	CcSEcCtD
Sitagliptin—Erythema multiforme—Dactinomycin—skin cancer	0.000603	0.00252	CcSEcCtD
Sitagliptin—Sinusitis—Temozolomide—skin cancer	0.000603	0.00252	CcSEcCtD
Sitagliptin—Dyspepsia—Imiquimod—skin cancer	0.000602	0.00251	CcSEcCtD
Sitagliptin—Pneumonia—Fluorouracil—skin cancer	0.000596	0.00249	CcSEcCtD
Sitagliptin—Decreased appetite—Imiquimod—skin cancer	0.000595	0.00248	CcSEcCtD
Sitagliptin—Infestation NOS—Fluorouracil—skin cancer	0.000592	0.00247	CcSEcCtD
Sitagliptin—Infestation—Fluorouracil—skin cancer	0.000592	0.00247	CcSEcCtD
Sitagliptin—Hypersensitivity—Vemurafenib—skin cancer	0.000591	0.00247	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00059	0.00247	CcSEcCtD
Sitagliptin—Fatigue—Imiquimod—skin cancer	0.00059	0.00246	CcSEcCtD
Sitagliptin—Pain—Imiquimod—skin cancer	0.000585	0.00244	CcSEcCtD
Sitagliptin—Renal impairment—Docetaxel—skin cancer	0.000583	0.00243	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00058	0.00242	CcSEcCtD
Sitagliptin—Urinary tract infection—Fluorouracil—skin cancer	0.000576	0.0024	CcSEcCtD
Sitagliptin—Asthenia—Vemurafenib—skin cancer	0.000575	0.0024	CcSEcCtD
Sitagliptin—Hypoaesthesia—Temozolomide—skin cancer	0.000574	0.0024	CcSEcCtD
Sitagliptin—Pharyngitis—Temozolomide—skin cancer	0.000573	0.00239	CcSEcCtD
Sitagliptin—Urinary tract disorder—Temozolomide—skin cancer	0.00057	0.00238	CcSEcCtD
Sitagliptin—Oedema peripheral—Temozolomide—skin cancer	0.000568	0.00237	CcSEcCtD
Sitagliptin—Connective tissue disorder—Temozolomide—skin cancer	0.000567	0.00237	CcSEcCtD
Sitagliptin—Urethral disorder—Temozolomide—skin cancer	0.000565	0.00236	CcSEcCtD
Sitagliptin—Feeling abnormal—Imiquimod—skin cancer	0.000564	0.00235	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Imiquimod—skin cancer	0.000559	0.00234	CcSEcCtD
Sitagliptin—Sinusitis—Fluorouracil—skin cancer	0.000555	0.00232	CcSEcCtD
Sitagliptin—Pain in extremity—Docetaxel—skin cancer	0.000555	0.00232	CcSEcCtD
Sitagliptin—Ill-defined disorder—Bleomycin—skin cancer	0.000552	0.00231	CcSEcCtD
Sitagliptin—Diarrhoea—Vemurafenib—skin cancer	0.000549	0.00229	CcSEcCtD
Sitagliptin—Migraine—Docetaxel—skin cancer	0.000546	0.00228	CcSEcCtD
Sitagliptin—Erythema multiforme—Temozolomide—skin cancer	0.000545	0.00228	CcSEcCtD
Sitagliptin—Urticaria—Imiquimod—skin cancer	0.000543	0.00227	CcSEcCtD
Sitagliptin—Abdominal pain—Imiquimod—skin cancer	0.000541	0.00226	CcSEcCtD
Sitagliptin—Eye disorder—Temozolomide—skin cancer	0.000539	0.00225	CcSEcCtD
Sitagliptin—Malaise—Bleomycin—skin cancer	0.000537	0.00224	CcSEcCtD
Sitagliptin—Cardiac disorder—Temozolomide—skin cancer	0.000535	0.00224	CcSEcCtD
Sitagliptin—Dizziness—Vemurafenib—skin cancer	0.00053	0.00222	CcSEcCtD
Sitagliptin—Hypoaesthesia—Fluorouracil—skin cancer	0.000529	0.00221	CcSEcCtD
Sitagliptin—Pharyngitis—Fluorouracil—skin cancer	0.000528	0.0022	CcSEcCtD
Sitagliptin—Angiopathy—Temozolomide—skin cancer	0.000523	0.00219	CcSEcCtD
Sitagliptin—Immune system disorder—Temozolomide—skin cancer	0.000521	0.00218	CcSEcCtD
Sitagliptin—Mediastinal disorder—Temozolomide—skin cancer	0.00052	0.00217	CcSEcCtD
Sitagliptin—Cough—Bleomycin—skin cancer	0.000519	0.00217	CcSEcCtD
Sitagliptin—Ill-defined disorder—Dactinomycin—skin cancer	0.000515	0.00215	CcSEcCtD
Sitagliptin—Vomiting—Vemurafenib—skin cancer	0.00051	0.00213	CcSEcCtD
Sitagliptin—Myalgia—Bleomycin—skin cancer	0.000507	0.00212	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Docetaxel—skin cancer	0.000506	0.00212	CcSEcCtD
Sitagliptin—Abdominal pain upper—Docetaxel—skin cancer	0.000506	0.00212	CcSEcCtD
Sitagliptin—Rash—Vemurafenib—skin cancer	0.000506	0.00211	CcSEcCtD
Sitagliptin—Mental disorder—Temozolomide—skin cancer	0.000505	0.00211	CcSEcCtD
Sitagliptin—Dermatitis—Vemurafenib—skin cancer	0.000505	0.00211	CcSEcCtD
Sitagliptin—Hypersensitivity—Imiquimod—skin cancer	0.000504	0.0021	CcSEcCtD
Sitagliptin—Headache—Vemurafenib—skin cancer	0.000502	0.0021	CcSEcCtD
Sitagliptin—Malnutrition—Temozolomide—skin cancer	0.000502	0.0021	CcSEcCtD
Sitagliptin—Breast disorder—Docetaxel—skin cancer	0.000501	0.00209	CcSEcCtD
Sitagliptin—Discomfort—Bleomycin—skin cancer	0.000501	0.00209	CcSEcCtD
Sitagliptin—Malaise—Dactinomycin—skin cancer	0.000501	0.00209	CcSEcCtD
Sitagliptin—Nasopharyngitis—Docetaxel—skin cancer	0.000496	0.00207	CcSEcCtD
Sitagliptin—Asthenia—Imiquimod—skin cancer	0.000491	0.00205	CcSEcCtD
Sitagliptin—Anaphylactic shock—Bleomycin—skin cancer	0.000486	0.00203	CcSEcCtD
Sitagliptin—Back pain—Temozolomide—skin cancer	0.000486	0.00203	CcSEcCtD
Sitagliptin—Infection—Bleomycin—skin cancer	0.000483	0.00202	CcSEcCtD
Sitagliptin—Nausea—Vemurafenib—skin cancer	0.000476	0.00199	CcSEcCtD
Sitagliptin—Vision blurred—Temozolomide—skin cancer	0.000473	0.00198	CcSEcCtD
Sitagliptin—Myalgia—Dactinomycin—skin cancer	0.000473	0.00197	CcSEcCtD
Sitagliptin—Diarrhoea—Imiquimod—skin cancer	0.000468	0.00195	CcSEcCtD
Sitagliptin—Discomfort—Dactinomycin—skin cancer	0.000467	0.00195	CcSEcCtD
Sitagliptin—Ill-defined disorder—Temozolomide—skin cancer	0.000466	0.00195	CcSEcCtD
Sitagliptin—Angioedema—Temozolomide—skin cancer	0.000459	0.00192	CcSEcCtD
Sitagliptin—Malaise—Temozolomide—skin cancer	0.000453	0.00189	CcSEcCtD
Sitagliptin—Dizziness—Imiquimod—skin cancer	0.000452	0.00189	CcSEcCtD
Sitagliptin—Vertigo—Temozolomide—skin cancer	0.000451	0.00188	CcSEcCtD
Sitagliptin—Infection—Dactinomycin—skin cancer	0.00045	0.00188	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000443	0.00185	CcSEcCtD
Sitagliptin—Cough—Temozolomide—skin cancer	0.000438	0.00183	CcSEcCtD
Sitagliptin—Weight increased—Docetaxel—skin cancer	0.000436	0.00182	CcSEcCtD
Sitagliptin—Vision blurred—Fluorouracil—skin cancer	0.000436	0.00182	CcSEcCtD
Sitagliptin—Vomiting—Imiquimod—skin cancer	0.000435	0.00182	CcSEcCtD
Sitagliptin—Hypertension—Temozolomide—skin cancer	0.000434	0.00181	CcSEcCtD
Sitagliptin—Rash—Imiquimod—skin cancer	0.000431	0.0018	CcSEcCtD
Sitagliptin—Dermatitis—Imiquimod—skin cancer	0.000431	0.0018	CcSEcCtD
Sitagliptin—Pneumonia—Docetaxel—skin cancer	0.00043	0.0018	CcSEcCtD
Sitagliptin—Headache—Imiquimod—skin cancer	0.000428	0.00179	CcSEcCtD
Sitagliptin—Myalgia—Temozolomide—skin cancer	0.000428	0.00179	CcSEcCtD
Sitagliptin—Arthralgia—Temozolomide—skin cancer	0.000428	0.00179	CcSEcCtD
Sitagliptin—Infestation NOS—Docetaxel—skin cancer	0.000427	0.00179	CcSEcCtD
Sitagliptin—Infestation—Docetaxel—skin cancer	0.000427	0.00179	CcSEcCtD
Sitagliptin—Anxiety—Temozolomide—skin cancer	0.000426	0.00178	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000425	0.00177	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000424	0.00177	CcSEcCtD
Sitagliptin—Discomfort—Temozolomide—skin cancer	0.000422	0.00176	CcSEcCtD
Sitagliptin—Decreased appetite—Bleomycin—skin cancer	0.000422	0.00176	CcSEcCtD
Sitagliptin—Renal failure—Docetaxel—skin cancer	0.00042	0.00175	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Docetaxel—skin cancer	0.000419	0.00175	CcSEcCtD
Sitagliptin—Dry mouth—Temozolomide—skin cancer	0.000418	0.00175	CcSEcCtD
Sitagliptin—Pain—Bleomycin—skin cancer	0.000415	0.00174	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000413	0.00172	CcSEcCtD
Sitagliptin—Anaphylactic shock—Temozolomide—skin cancer	0.00041	0.00171	CcSEcCtD
Sitagliptin—Infection—Temozolomide—skin cancer	0.000407	0.0017	CcSEcCtD
Sitagliptin—Nausea—Imiquimod—skin cancer	0.000406	0.0017	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Docetaxel—skin cancer	0.000404	0.00169	CcSEcCtD
Sitagliptin—Nervous system disorder—Temozolomide—skin cancer	0.000402	0.00168	CcSEcCtD
Sitagliptin—Feeling abnormal—Bleomycin—skin cancer	0.0004	0.00167	CcSEcCtD
Sitagliptin—Skin disorder—Temozolomide—skin cancer	0.000398	0.00166	CcSEcCtD
Sitagliptin—Myalgia—Fluorouracil—skin cancer	0.000394	0.00165	CcSEcCtD
Sitagliptin—Decreased appetite—Dactinomycin—skin cancer	0.000394	0.00165	CcSEcCtD
Sitagliptin—Fatigue—Dactinomycin—skin cancer	0.000391	0.00163	CcSEcCtD
Sitagliptin—Discomfort—Fluorouracil—skin cancer	0.000389	0.00163	CcSEcCtD
Sitagliptin—Pain—Dactinomycin—skin cancer	0.000387	0.00162	CcSEcCtD
Sitagliptin—Urticaria—Bleomycin—skin cancer	0.000386	0.00161	CcSEcCtD
Sitagliptin—Hypoaesthesia—Docetaxel—skin cancer	0.000382	0.00159	CcSEcCtD
Sitagliptin—Pharyngitis—Docetaxel—skin cancer	0.000381	0.00159	CcSEcCtD
Sitagliptin—Urinary tract disorder—Docetaxel—skin cancer	0.000379	0.00158	CcSEcCtD
Sitagliptin—Oedema peripheral—Docetaxel—skin cancer	0.000378	0.00158	CcSEcCtD
Sitagliptin—Anaphylactic shock—Fluorouracil—skin cancer	0.000378	0.00158	CcSEcCtD
Sitagliptin—Connective tissue disorder—Docetaxel—skin cancer	0.000377	0.00157	CcSEcCtD
Sitagliptin—Urethral disorder—Docetaxel—skin cancer	0.000376	0.00157	CcSEcCtD
Sitagliptin—Infection—Fluorouracil—skin cancer	0.000375	0.00157	CcSEcCtD
Sitagliptin—Feeling abnormal—Dactinomycin—skin cancer	0.000373	0.00156	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000373	0.00156	CcSEcCtD
Sitagliptin—Insomnia—Temozolomide—skin cancer	0.000371	0.00155	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000371	0.00155	CcSEcCtD
Sitagliptin—Nervous system disorder—Fluorouracil—skin cancer	0.00037	0.00155	CcSEcCtD
Sitagliptin—Somnolence—Temozolomide—skin cancer	0.000364	0.00152	CcSEcCtD
Sitagliptin—Erythema multiforme—Docetaxel—skin cancer	0.000363	0.00152	CcSEcCtD
Sitagliptin—Dyspepsia—Temozolomide—skin cancer	0.000361	0.00151	CcSEcCtD
Sitagliptin—Eye disorder—Docetaxel—skin cancer	0.000359	0.0015	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—skin cancer	0.000358	0.0015	CcSEcCtD
Sitagliptin—Hypersensitivity—Bleomycin—skin cancer	0.000358	0.0015	CcSEcCtD
Sitagliptin—Decreased appetite—Temozolomide—skin cancer	0.000356	0.00149	CcSEcCtD
Sitagliptin—Cardiac disorder—Docetaxel—skin cancer	0.000356	0.00149	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000354	0.00148	CcSEcCtD
Sitagliptin—Fatigue—Temozolomide—skin cancer	0.000353	0.00148	CcSEcCtD
Sitagliptin—Pain—Temozolomide—skin cancer	0.00035	0.00146	CcSEcCtD
Sitagliptin—Constipation—Temozolomide—skin cancer	0.00035	0.00146	CcSEcCtD
Sitagliptin—Asthenia—Bleomycin—skin cancer	0.000349	0.00146	CcSEcCtD
Sitagliptin—Angiopathy—Docetaxel—skin cancer	0.000348	0.00145	CcSEcCtD
Sitagliptin—Immune system disorder—Docetaxel—skin cancer	0.000347	0.00145	CcSEcCtD
Sitagliptin—Mediastinal disorder—Docetaxel—skin cancer	0.000346	0.00144	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000344	0.00144	CcSEcCtD
Sitagliptin—Insomnia—Fluorouracil—skin cancer	0.000342	0.00143	CcSEcCtD
Sitagliptin—Feeling abnormal—Temozolomide—skin cancer	0.000338	0.00141	CcSEcCtD
Sitagliptin—Mental disorder—Docetaxel—skin cancer	0.000336	0.0014	CcSEcCtD
Sitagliptin—Somnolence—Fluorouracil—skin cancer	0.000336	0.0014	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Temozolomide—skin cancer	0.000335	0.0014	CcSEcCtD
Sitagliptin—Malnutrition—Docetaxel—skin cancer	0.000334	0.0014	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—skin cancer	0.000334	0.00139	CcSEcCtD
Sitagliptin—Dyspepsia—Fluorouracil—skin cancer	0.000332	0.00139	CcSEcCtD
Sitagliptin—Decreased appetite—Fluorouracil—skin cancer	0.000328	0.00137	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000326	0.00136	CcSEcCtD
Sitagliptin—Urticaria—Temozolomide—skin cancer	0.000326	0.00136	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—skin cancer	0.000325	0.00136	CcSEcCtD
Sitagliptin—Abdominal pain—Temozolomide—skin cancer	0.000324	0.00135	CcSEcCtD
Sitagliptin—Back pain—Docetaxel—skin cancer	0.000323	0.00135	CcSEcCtD
Sitagliptin—Pain—Fluorouracil—skin cancer	0.000323	0.00135	CcSEcCtD
Sitagliptin—Muscle spasms—Docetaxel—skin cancer	0.000321	0.00134	CcSEcCtD
Sitagliptin—Feeling abnormal—Fluorouracil—skin cancer	0.000311	0.0013	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—skin cancer	0.00031	0.0013	CcSEcCtD
Sitagliptin—Vomiting—Bleomycin—skin cancer	0.000309	0.00129	CcSEcCtD
Sitagliptin—Rash—Bleomycin—skin cancer	0.000306	0.00128	CcSEcCtD
Sitagliptin—Dermatitis—Bleomycin—skin cancer	0.000306	0.00128	CcSEcCtD
Sitagliptin—Hypersensitivity—Temozolomide—skin cancer	0.000302	0.00126	CcSEcCtD
Sitagliptin—Urticaria—Fluorouracil—skin cancer	0.0003	0.00125	CcSEcCtD
Sitagliptin—Asthenia—Temozolomide—skin cancer	0.000294	0.00123	CcSEcCtD
Sitagliptin—Cough—Docetaxel—skin cancer	0.000291	0.00122	CcSEcCtD
Sitagliptin—Nausea—Bleomycin—skin cancer	0.000289	0.00121	CcSEcCtD
Sitagliptin—Hypertension—Docetaxel—skin cancer	0.000288	0.0012	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—skin cancer	0.000288	0.0012	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—skin cancer	0.000286	0.00119	CcSEcCtD
Sitagliptin—Myalgia—Docetaxel—skin cancer	0.000284	0.00119	CcSEcCtD
Sitagliptin—Arthralgia—Docetaxel—skin cancer	0.000284	0.00119	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000282	0.00118	CcSEcCtD
Sitagliptin—Diarrhoea—Temozolomide—skin cancer	0.00028	0.00117	CcSEcCtD
Sitagliptin—Hypersensitivity—Fluorouracil—skin cancer	0.000278	0.00116	CcSEcCtD
Sitagliptin—Dry mouth—Docetaxel—skin cancer	0.000278	0.00116	CcSEcCtD
Sitagliptin—Anaphylactic shock—Docetaxel—skin cancer	0.000273	0.00114	CcSEcCtD
Sitagliptin—Dizziness—Temozolomide—skin cancer	0.000271	0.00113	CcSEcCtD
Sitagliptin—Infection—Docetaxel—skin cancer	0.000271	0.00113	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—skin cancer	0.000269	0.00112	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—skin cancer	0.000267	0.00112	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—skin cancer	0.000265	0.00111	CcSEcCtD
Sitagliptin—Vomiting—Temozolomide—skin cancer	0.000261	0.00109	CcSEcCtD
Sitagliptin—Rash—Temozolomide—skin cancer	0.000258	0.00108	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—skin cancer	0.000258	0.00108	CcSEcCtD
Sitagliptin—Dermatitis—Temozolomide—skin cancer	0.000258	0.00108	CcSEcCtD
Sitagliptin—Headache—Temozolomide—skin cancer	0.000257	0.00107	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—skin cancer	0.00025	0.00104	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000248	0.00104	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—skin cancer	0.000247	0.00103	CcSEcCtD
Sitagliptin—Nausea—Temozolomide—skin cancer	0.000243	0.00102	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—skin cancer	0.000242	0.00101	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—skin cancer	0.00024	0.001	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—skin cancer	0.00024	0.001	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—skin cancer	0.000238	0.000995	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—skin cancer	0.000238	0.000994	CcSEcCtD
Sitagliptin—Decreased appetite—Docetaxel—skin cancer	0.000237	0.00099	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—skin cancer	0.000237	0.000988	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000235	0.000983	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—skin cancer	0.000235	0.000982	CcSEcCtD
Sitagliptin—Pain—Docetaxel—skin cancer	0.000233	0.000974	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—skin cancer	0.000233	0.000974	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—skin cancer	0.000225	0.000938	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—skin cancer	0.000224	0.000937	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—skin cancer	0.000223	0.000931	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—skin cancer	0.000215	0.0009	CcSEcCtD
Sitagliptin—Hypersensitivity—Docetaxel—skin cancer	0.000201	0.000839	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—skin cancer	0.000196	0.000817	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—skin cancer	0.000186	0.000779	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—skin cancer	0.00018	0.000753	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—skin cancer	0.000173	0.000724	CcSEcCtD
Sitagliptin—Rash—Docetaxel—skin cancer	0.000172	0.000718	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—skin cancer	0.000172	0.000717	CcSEcCtD
Sitagliptin—Headache—Docetaxel—skin cancer	0.000171	0.000713	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—skin cancer	0.000162	0.000676	CcSEcCtD
